Item 1. Financial Statements
ITEM 1: FINANCIAL STATEMENTS
COGNEX CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
Three-months Ended
April 5, 2026 March 30, 2025
(unaudited)
Revenue $ 268,437 $ 216,036
Cost of revenue 77,498 71,713
Gross profit 190,939 144,323
Research, development, and engineering expenses 37,025 34,727
Selling, general, and administrative expenses 94,041 83,504
Operating income 59,873 26,092
Foreign currency gain (loss) ( 1,345 ) ( 2,453 )
Investment income 4,836 3,990
Other income (expense) ( 1,607 ) 169
Income before income tax expense 61,757 27,798
Income tax expense 10,053 4,195
Net income $ 51,704 $ 23,603
Net income per weighted-average common and common-equivalent share:
Basic $ 0.31 $ 0.14
Diluted $ 0.31 $ 0.14
Weighted-average common and common-equivalent shares outstanding:
Basic 166,514 169,265
Diluted 168,386 170,391
Cash dividends per common share $ 0.085 $ 0.080
The accompanying notes are an integral part of these consolidated financial statements.
3
COGNEX CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(In thousands)
Three-months Ended
April 5, 2026 March 30, 2025
(unaudited)
Net income $ 51,704 $ 23,603
Other comprehensive income (loss), net of tax
Available-for-sale investments:
Net unrealized gain (loss), net of tax of $( 726 ) and $ 875 in the three-month periods, respectively
( 2,227 ) 2,711
Reclassification of net realized (gain) loss on the sale of available-for-sale investments into current operations ( 28 ) ( 27 )
Net change related to available-for-sale investments ( 2,255 ) 2,684
Net change related to foreign currency translation adjustments ( 4,983 ) 11,447
Other comprehensive income (loss), net of tax ( 7,238 ) 14,131
Total comprehensive income (loss) $ 44,466 $ 37,734
The accompanying notes are an integral part of these consolidated financial statements.
4
COGNEX CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands, except per share amounts)
April 5, 2026 December 31, 2025
(unaudited)
ASSETS
Current assets:
Cash and cash equivalents $ 237,343 $ 262,925
Current investments 59,413 74,037
Accounts receivable, net of allowance for credit losses of $ 781 and $ 728 in 2026 and 2025, respectively
170,721 146,713
Unbilled revenue 16,401 16,980
Inventories 135,549 137,889
Prepaid expenses and other current assets 70,922 58,702
Total current assets 690,349 697,246
Non-current investments 325,186 305,339
Property, plant, and equipment, net 84,291 86,015
Operating lease assets 69,709 72,310
Goodwill 382,818 386,279
Intangible assets, net 67,140 81,100
Deferred income taxes 381,100 383,272
Other assets 5,025 4,994
Total assets 2,005,618 2,016,555
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable $ 59,551 $ 50,203
Accrued expenses 77,399 91,397
Accrued income taxes 6,172 9,141
Deferred revenue and customer deposits 34,053 21,094
Operating lease liabilities 12,310 11,716
Total current liabilities 189,485 183,551
Non-current operating lease liabilities 61,707 64,870
Deferred income taxes 252,230 250,512
Reserve for income taxes 21,336 24,269
Other liabilities 1,891 1,452
Total liabilities 526,649 524,654
Commitments and contingencies (Note 7)
Shareholders’ equity:
Preferred stock, $ .01 par value – Authorized: 400 shares in 2026 and 2025, respectively; no shares issued and outstanding
— —
Common stock, $ .002 par value – Authorized: 300,000 shares in 2026 and 2025, respectively; issued and outstanding: 166,527 and 166,997 shares in 2026 and 2025, respectively
333 334
Additional paid-in capital 1,194,927 1,138,708
Retained earnings 344,443 406,355
Accumulated other comprehensive loss, net of tax ( 60,734 ) ( 53,496 )
Total shareholders’ equity 1,478,969 1,491,901
Total liabilities and shareholders' equity $ 2,005,618 $ 2,016,555
The accompanying notes are an integral part of these consolidated financial statements.
5
COGNEX CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
Three-months Ended
April 5, 2026 March 30, 2025
(unaudited)
Cash flows from operating activities:
Net income $ 51,704 $ 23,603
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Stock-based compensation expense 11,933 9,939
Depreciation of property, plant, and equipment 4,703 5,306
Amortization of intangible assets 2,532 2,628
Excess and obsolete inventory charges 364 197
Loss on sale of business, net of transaction costs 1,539 —
Deferred income taxes 4,740 ( 4,689 )
Other adjustments ( 380 ) ( 188 )
Change in operating assets and liabilities:
Accounts receivable ( 23,711 ) ( 17,183 )
Unbilled revenue 593 307
Inventories 8 5,474
Prepaid expenses and other current assets ( 12,212 ) 2,526
Accounts payable 9,390 4,996
Accrued expenses ( 13,554 ) ( 6,055 )
Accrued income taxes ( 2,905 ) ( 3,153 )
Deferred revenue and customer deposits 12,889 14,761
Other ( 2,540 ) 2,033
Net cash provided by (used in) operating activities 45,093 40,502
Cash flows from investing activities:
Purchases of investments ( 47,013 ) ( 113,297 )
Maturities and sales of investments 39,042 148,885
Net proceeds from sale of business 11,519 —
Purchases of property, plant, and equipment, net of proceeds ( 2,757 ) ( 2,501 )
Net cash provided by (used in) investing activities 791 33,087
Cash flows from financing activities:
Net payments from issuance of common stock under stock plans 44,290 ( 2,587 )
Repurchase of common stock ( 98,995 ) ( 102,233 )
Payment of dividends ( 14,196 ) ( 13,550 )
Net cash provided by (used in) financing activities ( 68,901 ) ( 118,370 )
Effect of foreign exchange rate changes on cash and cash equivalents ( 2,565 ) 2,431
Net change in cash and cash equivalents ( 25,582 ) ( 42,350 )
Cash and cash equivalents at beginning of period 262,925 186,094
Cash and cash equivalents at end of period $ 237,343 $ 143,744
The accompanying notes are an integral part of these consolidated financial statements.
6
COGNEX CORPORATION
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(In thousands of dollars, except per share amounts)
Common Stock Additional
Paid-in Capital Retained Earnings Accumulated
Other
Comprehensive
Loss Total
Shareholders’
Equity
Shares Par Value
Balance as of December 31, 2025
166,997 $ 334 $ 1,138,708 $ 406,355 $ ( 53,496 ) $ 1,491,901
Net issuance of common stock under stock plans 1,905 4 44,286 — — 44,290
Repurchase of common stock ( 2,375 ) ( 5 ) — ( 98,990 ) — ( 98,995 )
Excise tax on repurchase of common stock — — — ( 430 ) — ( 430 )
Stock-based compensation expense — — 11,933 — — 11,933
Payment of dividends ($ 0.085 per common share)
— — — ( 14,196 ) — ( 14,196 )
Net income — — — 51,704 — 51,704
Net unrealized gain (loss) on available-for-sale investments, net of tax of $( 726 )
— — — — ( 2,227 ) ( 2,227 )
Reclassification of net realized (gain) loss on the sale of available-for-sale investments — — — — ( 28 ) ( 28 )
Foreign currency translation adjustment — — — — ( 4,983 ) ( 4,983 )
Balance as of April 5, 2026 (unaudited)
166,527 $ 333 $ 1,194,927 $ 344,443 $ ( 60,734 ) $ 1,478,969
Common Stock Additional
Paid-in Capital Retained Earnings Accumulated
Other
Comprehensive
Loss Total
Shareholders’
Equity
Shares Par Value
Balance as of December 31, 2024
170,434 $ 341 $ 1,090,638 $ 499,303 $ ( 72,777 ) $ 1,517,505
Net issuance of common stock under stock plans 478 1 ( 2,588 ) — — ( 2,587 )
Repurchase of common stock ( 3,047 ) ( 6 ) — ( 103,407 ) — ( 103,413 )
Stock-based compensation expense — — 9,939 — — 9,939
Payment of dividends ($ 0.080 per common share)
— — — ( 13,550 ) — ( 13,550 )
Net income — — — 23,603 — 23,603
Net unrealized gain (loss) on available-for-sale investments, net of tax of $ 875
— — — — 2,711 2,711
Reclassification of net realized (gain) loss on the sale of available-for-sale investments — — — — ( 27 ) ( 27 )
Foreign currency translation adjustment — — — — 11,447 11,447
Balance as of March 30, 2025 (unaudited)
167,865 $ 336 $ 1,097,989 $ 405,949 $ ( 58,646 ) $ 1,445,628
The accompanying notes are an integral part of these consolidated financial statements.
7
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
NOTE 1: Summary of Significant Accounting Policies
As permitted by the rules of the Securities and Exchange Commission applicable to Quarterly Reports on Form 10-Q, these notes are condensed and do not contain all disclosures required by accounting principles generally accepted in the United States ("GAAP"). Reference should be made to the consolidated financial statements and related notes included in Cognex Corporation's ("Cognex" or the "Company") Annual Report on Form 10-K for the year ended December 31, 2025 for a full description of other significant accounting policies.
In the opinion of the management of the Company, the accompanying consolidated unaudited financial statements contain all adjustments, consisting of normal, recurring adjustments and financial statement reclassifications necessary to present fairly the Company’s financial position as of April 5, 2026, and the results of its operations for the three-month periods ended April 5, 2026 and March 30, 2025, and changes in shareholders’ equity, comprehensive income, and cash flows for the periods presented.
The results disclosed in the Consolidated Statements of Operations for the three-month period ended April 5, 2026 are not necessarily indicative of the results to be expected for the full year.
NOTE 2: New Pronouncements
Accounting Standards Update (ASU) 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40)
This ASU aims to enhance transparency for users of financial statements by requiring public business entities to disaggregate specific expense categories. ASU 2024-03 mandates disclosures in the notes to financial statements detailing the composition and trends of key expense categories within major income statement captions. These enhanced disclosures are intended to help investors more effectively assess the entity’s performance, understand its cost structure, and make more accurate forecasts of future cash flows. For public business entities, ASU 2024-03 is effective for annual periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. The adoption will result in disclosure changes only. Management is currently evaluating the impact that adopting ASU 2024-03 would have on the Company's financial statement disclosures.
Accounting Standards Update (ASU) 2025-06 - Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software
The amendments in this ASU update the accounting and disclosure guidance for internal-use software to better reflect modern, iterative development practices. The amendments replace the former “development stage” model with a judgment-based framework and require entities to evaluate whether significant development uncertainty exists before capitalizing costs. The ASU also incorporates website development guidance into Subtopic 350-40 and aligns disclosures for capitalized software with those for property, plant, and equipment. For public business entities, the amendments in this ASU are effective for annual reporting periods beginning after December 15, 2027, and for interim periods within those annual reporting periods, with early adoption permitted. Management is currently evaluating the impact that adopting ASU 2025-06 would have on the Company's financial statements and disclosures.
Accounting Standards Update (ASU) 2025-11 - Interim Reporting (Topic 270): Narrow-Scope Improvements
The amendments in this ASU improve the navigability and clarity of interim reporting requirements without changing the fundamental nature or scope of existing disclosures. The ASU also clarifies when Topic 270 applies, specifies the form and content of interim financial statements and notes, and introduces a comprehensive list of required interim disclosures compiled from across the Codification. The ASU also adds a disclosure principle requiring entities to disclose events occurring after the most recent annual reporting period that have a material impact on the entity. For public business entities, the amendments in this ASU are effective for annual reporting periods beginning after December 15, 2027, and for interim periods within annual reporting periods beginning after December 15, 2028, with early adoption permitted. Management is currently evaluating the impact that adopting ASU 2025-11 would have on the Company's disclosures.
Accounting Standards Update (ASU) 2025-12 - Codification Improvements
The amendments in this ASU make incremental improvements to clarify, correct, and enhance the usability of the Accounting Standards Codification. The amendments address technical corrections, unintended application issues,
8
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
and minor improvements across numerous topics, and are not expected to significantly affect current accounting practice. Key areas of clarification include diluted earnings per share calculations, disclosure requirements for lease receivables, guidance on beneficial interests, methods for accounting for treasury stock retirements, and the treatment of receivables transferred from contracts with customers. For public business entities, the amendments in this ASU are effective for annual reporting periods beginning after December 15, 2026, and for interim periods within those annual reporting periods, with early adoption permitted. Management is currently evaluating the impact that adopting ASU 2025-10 would have on the Company's financial statements and disclosures.
NOTE 3: Financial Instruments
Cash, Cash Equivalents, and Investments
The following table summarizes the Company’s cash, cash equivalents, and investments as of April 5, 2026 (in thousands):
Fair Value Level Amortized
Cost Gross
Unrealized
Gains Gross
Unrealized
Losses Fair Value Cash and Cash Equivalents Current Investments Non-current Investments
Cash $ 178,191 $ — $ — $ 178,191 $ 178,191 $ — $ —
Money market instruments Level 1 59,152 — — 59,152 59,152 — —
Corporate bonds Level 2 360,314 1,399 ( 1,304 ) 360,409 — 58,428 301,981
Treasury notes Level 2 20,365 26 ( 26 ) 20,365 — 985 19,380
Asset-backed securities Level 2 4,116 — ( 291 ) 3,825 — — 3,825
Total $ 622,138 $ 1,425 $ ( 1,621 ) $ 621,942 $ 237,343 $ 59,413 $ 325,186
The following table summarizes the Company’s cash, cash equivalents, and investments as of December 31, 2025 (in thousands):
Fair Value Level Amortized
Cost Gross
Unrealized
Gains Gross
Unrealized
Losses Fair Value Cash and Cash Equivalents Current Investments Non-current Investments
Cash $ 199,755 $ — $ — $ 199,755 $ 199,755 $ — $ —
Money market instruments Level 1 63,170 — — 63,170 63,170 — —
Corporate bonds Level 2 342,442 3,149 ( 240 ) 345,351 — 66,625 278,726
Treasury notes Level 2 29,676 167 — 29,843 — 7,412 22,431
Asset-backed securities Level 2 4,471 — ( 289 ) 4,182 — — 4,182
Total $ 639,514 $ 3,316 $ ( 529 ) $ 642,301 $ 262,925 $ 74,037 $ 305,339
The Company’s money market instruments are reported at fair value based upon the daily market price for identical assets in active markets and are therefore classified as Level 1. Money market instruments consist of treasury bills, corporate commercial paper, and certificates of deposit that are highly liquid and mature in three months or less. Corporate bonds consist of debt securities issued by both domestic and foreign companies; treasury notes consist of debt securities issued by the U.S. government; and asset-backed securities consist of debt securities collateralized by pools of receivables or loans with credit enhancement. All of the Company's securities as of April 5, 2026 and December 31, 2025 were denominated in U.S. Dollars, with the exception of certain certificates of deposit.
The Company’s debt securities are reported at fair value based on model-driven valuations in which all significant inputs are observable or can be derived from or corroborated by observable market data for substantially the full term of the asset or liability and are therefore classified as Level 2. Management is responsible for estimating the fair value of these financial instruments, and in doing so, considers valuations provided by a large, third-party pricing service. This service maintains regular contact with market makers, brokers, dealers, and analysts to gather information on market movement, direction, trends, and other specific data. They use this information to structure yield curves for various types of debt securities and arrive at the daily valuations.
Accrued interest receivable is recorded in "Prepaid expenses and other current assets" on the Consolidated Balance Sheets and amounted to $ 3,793,000 and $ 3,852,000 as of April 5, 2026 and December 31, 2025,
9
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
respectively.
Realized Gains (Losses) on Debt Securities
The following table summarizes the Company's gross realized gains and losses on the sale of debt securities for the three-month periods ended April 5, 2026 and March 30, 2025 (in thousands):
Three-months Ended
April 5, 2026 March 30, 2025
Gross realized gains $ 28 $ 27
Gross realized losses — —
Net realized gains (losses) $ 28 $ 27
Realized gains and losses are included in "Investment income" on the Consolidated Statements of Operations. Prior to the sale of these securities, unrealized gains and losses for these debt securities, net of tax, were recorded in shareholders’ equity as accumulated other comprehensive income (loss).
Unrealized Losses on Debt Securities
The following table summarizes the Company’s gross unrealized losses and fair values for available-for-sale investments in an unrealized loss position as of April 5, 2026 (in thousands):
Unrealized Loss Position For:
Less than 12 Months 12 Months or Greater Total
Fair Value Unrealized
Losses Fair Value Unrealized
Losses Fair Value Unrealized
Losses
Corporate bonds $ 138,944 $ ( 1,242 ) $ 11,537 $ ( 62 ) $ 150,481 $ ( 1,304 )
Treasury notes 7,167 ( 26 ) — — 7,167 ( 26 )
Asset-backed securities — — 3,825 ( 291 ) 3,825 ( 291 )
$ 146,111 $ ( 1,268 ) $ 15,362 $ ( 353 ) $ 161,473 $ ( 1,621 )
The following table summarizes the Company’s gross unrealized losses and fair values for available-for-sale investments in an unrealized loss position as of December 31, 2025 (in thousands):
Unrealized Loss Position For:
Less than 12 Months 12 Months or Greater Total
Fair Value Unrealized
Losses Fair Value Unrealized
Losses Fair Value Unrealized
Losses
Corporate bonds $ 30,602 $ ( 73 ) $ 22,412 $ ( 167 ) $ 53,014 $ ( 240 )
Asset-backed securities — — 4,182 ( 289 ) 4,182 ( 289 )
$ 30,602 $ ( 73 ) $ 26,594 $ ( 456 ) $ 57,196 $ ( 529 )
Management monitors debt securities that are in an unrealized loss position to determine whether a loss exists related to the credit quality of the issuer. When developing an estimate of expected credit losses, management considers all relevant information including historical experience, current conditions, and reasonable forecasts of expected future cash flows. Based on this evaluation, no allowance for credit losses on debt securities was recorded as of April 5, 2026 or December 31, 2025. Management currently intends to hold these securities to full value recovery at maturity.
10
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Debt Securities Maturities
The following table presents the effective maturity dates of the Company’s available-for-sale investments as of April 5, 2026 (in thousands):
<1 year 1-2 Years 2-3 Years 3-4 Years 4-5 Years Total
Corporate bonds $ 58,428 $ 82,557 $ 115,212 $ 53,935 $ 50,277 $ 360,409
Treasury notes 985 17,389 1,991 — — 20,365
Asset-backed securities — — — 3,728 97 3,825
$ 59,413 $ 99,946 $ 117,203 $ 57,663 $ 50,374 $ 384,599
Derivative Instruments
The Company’s foreign currency risk management strategy is designed to mitigate the potential financial impact of changes in the value of transactions and balances denominated in foreign currencies resulting from changes in foreign currency exchange rates. The Company enters into economic hedges utilizing foreign currency forward contracts with maturities of generally up to three months but not greater than one year to manage the exposure to fluctuations in foreign currency exchange rates arising primarily from foreign-denominated receivables and payables. The gains and losses on these derivatives are intended to be offset by the changes in the fair value of the assets and liabilities being hedged. These economic hedges are not designated as hedging instruments for hedge accounting treatment.
The Company had the following outstanding forward contracts (in thousands):
April 5, 2026 December 31, 2025
Currency Notional
Value USD
Equivalent Notional
Value USD
Equivalent
Derivatives Not Designated as Hedging Instruments:
Singapore Dollar 34,000 $ 27,335 — $ —
Chinese Renminbi 170,000 24,734 20,000 2,865
Euro 15,000 17,343 — —
Mexican Peso 150,000 8,380 160,000 8,881
Hungarian Forint 2,500,000 7,517 2,500,000 7,600
British Pound 4,000 5,297 4,000 5,383
Japanese Yen 800,000 5,034 400,000 2,563
Swiss Franc 2,000 2,515 — —
Indian Rupee 225,000 2,399 400,000 4,436
Korean Won 3,000,000 1,988 9,000,000 6,239
11
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Information regarding the fair value of the outstanding forward contracts was as follows (in thousands):
Asset Derivatives Liability Derivatives
Fair Value Fair Value
Balance Sheet Location Fair Value Level April 5, 2026 December 31, 2025 Balance Sheet Location Fair Value Level April 5, 2026 December 31, 2025
Derivatives Not Designated as Hedging Instruments:
Economic hedge forward contracts Prepaid expenses and other current assets Level 2 $ 985 $ 791 Accrued expenses Level 2 $ 1,856 $ 367
Activity:
Gross amounts recognized $ 985 $ 791 $ 1,856 $ 367
Gross amounts offset — — — —
Net amounts presented on the Consolidated Balance Sheets $ 985 $ 791 $ 1,856 $ 367
The Company’s forward contracts are reported at fair value based on model-driven valuations in which all significant inputs are observable or can be derived from or corroborated by observable market data for substantially the full term of the asset or liability and are therefore classified as Level 2. The Company's forward contracts are typically traded or executed in over-the-counter markets with a high degree of pricing transparency. The market participants are generally large commercial banks.
Information regarding the effect of derivative instruments on the Consolidated Statements of Operations was as follows (in thousands):
Statement of Operations Location Three-months Ended
April 5, 2026 March 30, 2025
Derivatives Not Designated as Hedging Instruments:
Gains (losses) recognized in current operations Foreign currency gain (loss) $ ( 761 ) $ ( 547 )
Activities related to derivative instruments are reflected within "Net cash provided by (used in) operating activities" on the Consolidated Statements of Cash Flows.
NOTE 4: Inventories
Inventories consisted of the following (in thousands):
April 5, 2026 December 31, 2025
Raw materials $ 69,896 $ 75,417
Work-in-process 6,446 4,877
Finished goods 59,207 57,595
$ 135,549 $ 137,889
12
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
NOTE 5: Goodwill and Intangible Assets
The changes in the carrying value of goodwill were as follows (in thousands):
Balance as of December 31, 2025 $ 386,279
Business disposal (refer to Note 13) ( 541 )
Foreign exchange rate changes ( 2,920 )
Balance as of April 5, 2026 $ 382,818
Amortized intangible assets as of April 5, 2026 consisted of the following (in thousands):
Gross
Carrying
Value Accumulated
Amortization Net
Carrying
Value
Customer relationships $ 54,907 $ ( 13,760 ) $ 41,147
Completed technologies 58,175 ( 32,320 ) 25,855
Trademarks 799 ( 666 ) 133
Non-compete agreements 60 ( 55 ) 5
Balance as of April 5, 2026 $ 113,941 $ ( 46,801 ) $ 67,140
Amortized intangible assets as of December 31, 2025 consisted of the following (in thousands):
Gross
Carrying
Value Accumulated
Amortization Net
Carrying
Value
Customer relationships $ 68,241 $ ( 14,843 ) $ 53,398
Completed technologies 58,603 ( 31,110 ) 27,493
Trademarks 812 ( 610 ) 202
Non-compete agreements 60 ( 53 ) 7
Balance as of December 31, 2025 $ 127,716 $ ( 46,616 ) $ 81,100
Future amortization expense related to intangible assets as of April 5, 2026 is as follows (in thousands):
Amount
Remainder of fiscal 2026 $ 6,611
2027 7,968
2028 7,238
2029 7,238
2030 6,695
2031 6,695
Thereafter 24,695
$ 67,140
On April 1, 2026, the Company completed the divestiture of its Japan-focused trading business, which was originally acquired as part of the acquisition of Moritex Corporation in 2023. In connection with the divestiture, the Company derecognized $ 541,000 of goodwill and $ 10,636,000 of customer relationship intangible assets, representing the net carrying amounts attributable to the disposed business.
13
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
NOTE 6: Warranty Obligations
The Company records the estimated cost of fulfilling product warranties at the time of sale based upon historical costs to fulfill claims. Obligations may also be recorded subsequent to the time of sale whenever specific events or changes in circumstances impacting product quality become known that would not have been taken into account using historical data. While we engage in extensive product quality programs and processes, including actively monitoring and evaluating the quality of our component suppliers and third-party contract manufacturers, the Company’s warranty obligation is affected by product failure rates, material usage, and service delivery costs incurred in correcting a product failure. An adverse change in any of these factors may result in the need for additional warranty provisions. Warranty obligations are included in “Accrued expenses” on the Consolidated Balance Sheets.
The changes in the warranty obligation for the three-month periods ended April 5, 2026 and March 30, 2025 were as follows (in thousands):
Balance as of December 31, 2025 $ 5,474
Provisions for warranties issued during the period 1,301
Fulfillment of warranty obligations ( 1,127 )
Balance as of April 5, 2026 $ 5,648
Balance as of December 31, 2024 $ 5,140
Provisions for warranties issued during the period 1,453
Fulfillment of warranty obligations ( 873 )
Foreign exchange rate changes 8
Balance as of March 30, 2025 $ 5,728
NOTE 7: Commitments and Contingencies
As of April 5, 2026, the Company had outstanding purchase orders totaling $ 50,616,000 to procure inventory from various vendors. Certain of these purchase orders may be canceled by the Company, subject to cancellation penalties. These purchase commitments relate primarily to expected sales in the next twelve months.
A significant portion of the Company's outstanding inventory purchase orders as of April 5, 2026, as well as additional preauthorized commitments to procure strategic components based on the Company's expected customer demand, are placed with the Company's primary contract manufacturer for the Company's assembled products. The Company has the obligation to purchase any non-cancelable and non-returnable components that have been purchased by the contract manufacturer with the Company's preauthorization, when these components have not been consumed within the period defined in the terms of the Company's agreement with this contract manufacturer. While the Company typically expects such purchased components to be used in future production of Cognex finished goods, these components are considered in the Company's reserve estimate for excess and obsolete inventory. Furthermore, the Company accrues for losses on commitments for the future purchase of non-cancelable and non-returnable components from this contract manufacturer at the time that circumstances, such as changes in demand, indicate that the value of the components may not be recoverable, the loss is probable, and management has the ability to reasonably estimate the amount of the loss. The Company's accrual for such losses was not material as of April 5, 2026 and March 30, 2025.
Various claims and legal proceedings generally incidental to the normal course of business are pending or threatened on behalf of or against the Company. While we cannot predict the outcome of these matters, we believe that any liability arising from them will not have a material adverse effect on our financial position, liquidity, or results of operations.
14
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
NOTE 8: Stockholders' Equity
Stock Repurchase Program
In March 2022, the Company's Board of Directors (the "Board") authorized a program providing for the repurchase of $ 500,000,000 of the Company's common stock (the "Program"). Under the Program, in addition to repurchases made in prior periods, the Company repurchased 3,047,000 shares at a total cost of $ 103,413,000 during the three-month period ended March 30, 2025 and 2,375,000 shares at a total cost of $ 98,995,000 during the three-month period ended April 5, 2026, leaving a remaining balance of $ 16,025,000 as of April 5, 2026. On February 11, 2026, the Board authorized the repurchase of an additional $ 500,000,000 of the Company's common stock upon completion of the Program. The Company may repurchase shares under these programs in future periods depending on a variety of factors, including, among other things, the impact of dilution from employee stock awards, stock price, share availability, and cash requirements. The Company is authorized to make repurchases of its common stock through open market purchases, pursuant to Rule 10b5-1 trading plans, or in privately negotiated transactions.
Stock-Based Compensation Expense
The Company’s stock-based awards that result in compensation expense consist of stock options, restricted stock units ("RSUs"), and performance restricted stock units ("PRSUs").
The following table summarizes the number of stock-based awards granted by the Company and the weighted-average grant-date fair value per unit for the three-month periods ended April 5, 2026 and March 30, 2025:
Three-months Ended
April 5, 2026 March 30, 2025
Stock-Based Awards Granted
(in
thousands) Weighted-
Average
Grant-Date Fair Value Stock-Based Awards Granted
(in
thousands) Weighted-
Average
Grant-Date Fair Value
Stock options 326 $ 22.13 1,360 $ 12.32
Restricted stock units 745 $ 56.36 1,248 $ 32.35
Performance restricted stock units 71 $ 56.13 184 $ 32.14
1,142 2,792
During the three-month periods ended April 5, 2026 and March 30, 2025, the Company granted PRSUs that vest upon the achievement of (1) a service condition of three years of continuous employment and (2) a performance condition established by the Compensation Committee of the Board as of the grant date. The number of shares earned could range between 0 % and 120 % based on achievement of the performance condition, which includes certain financial targets. The fair value of these PRSUs is calculated based on the observable market price of the Company's stock on the grant date less the present value of expected future dividends. Compensation expense for these PRSUs is recognized based on the probable outcome of the performance condition with a cumulative catch-up adjustment for prior periods in the period that the probable outcome changes.
The Company stratifies its employee population into two groups: one consisting of senior management and members of the Board and another consisting of all other employees. The Company currently applies an estimated annual forfeiture rate of 12 % to all stock-based awards for senior management and a rate of 13 % for all other employees. Each year during the first quarter, the Company revises its forfeiture rate based on updated estimates of employee turnover. Credits of $ 1,576,000 and $ 4,789,000 were recorded in 2026 and 2025, respectively, to true up previously recorded compensation expense for this forfeiture rate revision. Additionally in the first quarter of 2026, the Company revised its forfeiture rate applied specifically to stock-based awards for its former chief executive officer to 100% due to his retirement from the Board effective March 2, 2026, resulting in credits of $ 5,031,000 .
As of April 5, 2026, total unrecognized compensation expense, net of estimated forfeitures, related to non-vested equity awards, including stock options, RSUs, and PRSUs, was $ 68,857,000 , which is expected to be recognized over a weighted-average period of 1.8 years.
15
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
The following table presents the stock-based compensation expense by caption for each period presented on the Consolidated Statements of Operations (in thousands):
Three-months Ended
April 5, 2026 March 30, 2025
Cost of revenue $ 925 $ 668
Research, development, and engineering 5,094 $ 4,696
Selling, general, and administrative 5,914 $ 4,575
Total stock-based compensation expense $ 11,933 $ 9,939
No compensation expense was capitalized as of April 5, 2026 or December 31, 2025.
NOTE 9: Revenue Recognition
The following table summarizes disaggregated revenue information by geographic area based upon the customer's country of domicile (in thousands):
Three-months Ended
April 5, 2026 March 30, 2025
Americas $ 121,301 $ 99,374
Europe 63,815 46,790
Greater China 37,759 26,946
Other Asia 45,562 42,926
268,437 216,036
The following table summarizes disaggregated revenue information by revenue type (in thousands):
Three-months Ended
April 5, 2026 March 30, 2025
Standard products and services 254,439 204,510
Application-specific customer solutions 13,998 11,526
268,437 216,036
Costs to Fulfill a Contract
Costs to fulfill a contract are included in "Prepaid expenses and other current assets" on the Consolidated Balance Sheets and amounted to $ 17,224,000 and $ 10,592,000 as of April 5, 2026 and December 31, 2025, respectively.
Accounts Receivable, Contract Assets, and Contract Liabilities
Accounts receivable represent amounts billed and currently due from customers which are reported at their net estimated realizable value. The Company maintains an allowance against its accounts receivable for credit losses. Contract assets consist of unbilled revenue which arises when revenue is recognized in advance of billing for certain application-specific customer solutions contracts. Contract liabilities consist of deferred revenue and customer deposits which arise when amounts are billed to or collected from customers in advance of revenue recognition.
16
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
The following table summarizes the deferred revenue and customer deposits activity for the three-month periods ended April 5, 2026 and March 30, 2025 (in thousands):
Balance as of December 31, 2025 $ 21,094
Deferral of revenue billed in the current period, net of recognition 21,134
Recognition of revenue deferred in prior period ( 8,042 )
Reclassified to accounts receivable ( 203 )
Foreign exchange rate changes 70
Balance as of April 5, 2026 $ 34,053
Balance at December 31, 2024 $ 25,035
Deferral of revenue billed in the current period, net of recognition 22,175
Recognition of revenue deferred in prior period ( 7,414 )
Foreign exchange rate changes 62
Balance as of March 30, 2025 $ 39,858
As a practical expedient, the Company has elected not to disclose the aggregate amount of the transaction price allocated to unsatisfied performance obligations for our contracts that have an original expected duration of less than one year. The remaining unsatisfied performance obligations for our contracts that have an original expected duration of more than one year, primarily related to extended warranties, are not material.
NOTE 10: Income Taxes
The Company's effective tax rate was 16 % and 15 % for the three-month periods ended April 5, 2026 and March 30, 2025, respectively.
The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea, and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.7 % in Japan, and 22 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These foreign tax rate differences resulted in a favorable impact to the effective tax rate for both the three-month periods ended April 5, 2026 and March 30, 2025.
For the three-month period ended April 5, 2026, the Company recorded a net discrete tax benefit of $ 1,179,000 , primarily driven by excess tax benefits related to stock‑based compensation. For the three-month period ended March 30, 2025, the Company recorded a net discrete tax benefit of $ 307,000 , primarily driven by deferred tax adjustments partially offset by excess tax liabilities related to stock‑based compensation.
The Company’s reserve for income taxes, including gross interest and penalties, was $ 24,195,000 as of April 5, 2026, of which $ 21,336,000 was classified as a non-current liability and $ 2,859,000 was classified as an offset to deferred tax assets. If the Company’s tax positions were sustained or the statutes of limitations related to certain positions expired, these reserves would be released and income tax expense would be reduced in a future period.
Within the United States, the tax years 2022 through 2025 remain open to examination by the Internal Revenue Service, and 2021 through 2025 remain open to examination by various state tax authorities. The tax years 2017 through 2025 remain open to examination by various international taxing authorities in other jurisdictions in which the Company operates.
17
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
The Organization for Economic Cooperation and Development ("OECD") provided model rules for a 15% global minimum tax, known as Pillar Two. Pillar Two has now been enacted by most key non-United States jurisdictions where the Company operates. From 2024 to 2025, the Company met at least one of the tests under the transitional safe harbor exception for all jurisdictions except for the United States. During 2024 and 2025, the Company had favorable treatment under a safe harbor that exempted U.S. multinational entity exposure to top-up tax under Pillar Two, which expired at the end of 2025. In 2026, OECD released the framework for a side-by-side system, providing a permanent solution for multinational entities headquartered in jurisdictions that had not fully adopted the Pillar Two Model Rules into domestic law but have current domestic tax regimes meeting certain requirements, including a high statutory tax rates (at least 20%) that had not fully adopted the Pillar Two Model Rules into domestic law. However, uncertainty remains related to the implementation of this arrangement across the various jurisdictions in which the Company operates, and the Company is now subject to top-up tax effective January 1, 2026. This minimum tax is treated as a period cost but did not have a material impact on the Company's financial results of operations for the three-month period ended April 5, 2026. The Company continues to monitor legislative developments.
NOTE 11: Earnings per Share
The following table shows the computation of basic and diluted earnings per share for the three-month periods ended April 5, 2026 and March 30, 2025 (in thousands, except per share amounts):
Three-months Ended
April 5, 2026 March 30, 2025
Net income 51,704 23,603
Basic weighted-average common and common-equivalent shares outstanding 166,514 169,265
Effect of dilutive stock-based awards 1,872 1,126
Diluted weighted-average common and common-equivalent shares outstanding 168,386 170,391
Earnings per share
Basic 0.31 0.14
Diluted 0.31 0.14
The computation of diluted weighted-average common shares outstanding excludes the following weighted average anti-dilutive stock-based awards outstanding for the three-month periods ended April 5, 2026 and March 30, 2025 (in thousands):
Three-months Ended
April 5, 2026 March 30, 2025
Stock options 5,945 9,765
Restricted stock units 376 —
Performance restricted stock units 41 —
Total weighted average anti-dilutive stock-based awards outstanding 6,362 9,765
NOTE 12: Segment Information
The Company operates in one segment, machine vision technology. The Company has a single, company-wide management team that administers operations as a whole rather than as discrete operating segments. The Company’s chief operating decision maker is the chief executive officer, who assesses performance and allocates resources at the corporate level, as compared to the geography, product line, or end market levels. The Company offers a variety of machine vision products that have similar economic characteristics and are distributed by the same sales channels to the same types of customers.
18
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
The measure of segment profit or loss for the Company's single segment is net income. Segment expenses were disaggregated based on the information the chief operating decision maker uses to assess performance and allocate resources considering both quantitative and qualitative factors. The following table summarizes significant segment expenses, which represents the difference between segment revenue and segment net income (in thousands):
Three-months Ended
April 5, 2026 March 30, 2025
Revenue $ 268,437 $ 216,036
Less:
Cost of revenue (1)
77,498 71,713
Gross profit 190,939 144,323
Less:
Research, development, and engineering expenses
Salaries and fringe benefits 19,074 18,274
Incentive compensation (2)
2,024 1,071
Stock-based compensation 5,094 4,696
Depreciation and amortization 502 755
Other segment expenses (3)
10,331 9,931
Total research, development, and engineering expenses 37,025 34,727
Selling, general, and administrative expenses
Salaries and fringe benefits 45,026 42,195
Incentive compensation (2)
14,326 10,882
Stock-based compensation 5,914 4,575
Depreciation and amortization 3,666 4,161
Other segment expenses (3)
25,109 21,691
Total selling, general, and administrative expenses 94,041 83,504
Operating income 59,873 26,092
Foreign currency gain (loss) ( 1,345 ) ( 2,453 )
Investment income 4,836 3,990
Other income (expense) ( 1,607 ) 169
Income before income tax expense 61,757 27,798
Income tax expense 10,053 4,195
Net income $ 51,704 $ 23,603
(1) Cost of revenue includes depreciation and amortization expense (including amortization of acquired technologies) of $ 3,067,000 and $ 3,018,000 for the three-month periods ended April 5, 2026 and March 30, 2025, respectively.
(2) Incentive compensation includes company bonus and sales commissions.
(3) Other segment expenses include outside services, prototyping materials, sales demonstration equipment, travel and entertainment, marketing programs, rent, and reorganization charges, among other less significant expenses.
Segment assets amounted to $ 2,005,618,000 and $ 2,016,555,000 as of April 5, 2026 and December 31, 2025, respectively.
19
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
NOTE 13: Business Disposal
On April 1, 2026, the Company completed the divestiture of its Japan-focused trading business, which was originally acquired as part of the acquisition of Moritex Corporation ("Moritex") in 2023. The disposal group met the definition of a business under ASC 805 as it included inputs and substantive processes that together significantly contributed to the ability to create outputs. The transaction resulted in gross proceeds received from the buyer of ¥ 1,882,688,000 Japanese Yen ($ 12,049,000 U.S. Dollars based on the closing-date foreign exchange rate).
Carrying amounts of major assets and liabilities included as part of the disposal group were as follows (in thousands):
Amount
Inventories $ 2,195
Goodwill 541
Intangible assets, net (customer relationships) 10,636
Total assets $ 13,372
Accrued expenses (retirement benefit obligation) $ 314
Total liabilities $ 314
The Company recognized a pre-tax loss of ¥ 240,445,000 Japanese Yen ($ 1,539,000 U.S. Dollars based on the closing-date foreign exchange rate), which includes direct costs associated with the divestiture incurred during the three-month period ended April 5, 2026 of ¥ 82,895,000 Japanese Yen ($ 530,000 U.S. Dollars based on the closing-date foreign exchange rate) and is presented within “Other income (expense)” in the Consolidated Statements of Operations for the three-month period ended April 5, 2026. The transaction did not have a material impact on the Company’s income tax expense or tax position.
The divested business was not considered core to the Company’s operations and its sale does not represent a strategic shift that would have a major effect on the Company’s operations or financial results. For the year ended December 31, 2025, the divested business accounted for approximately 2 % of the Company’s overall revenue. Accordingly, the transaction does not meet the criteria for discontinued operations presentation and as a result, the results of operations of the disposal group are presented within continued operations for the three-month period ended April 5, 2026. The business was not a reportable segment and was included within the Company’s single operating segment as described in Note 13, Segment Information.
The Company allocated ¥ 1,661,888,000 Japanese Yen ($ 10,636,000 U.S. Dollars based on the closing-date foreign exchange rate) of net customer relationships to the disposal group based on the relative fair value attributable to the disposal group using an income approach, which the Company determined to be the most appropriate basis for allocation as it best reflects the economic benefits and expected future cash flows associated with these relationships. The income approach is consistent with the valuation methodology used in the original acquisition‑date valuation and incorporates management’s best estimates and assumptions that a market participant would consider.
The Company allocated ¥ 84,563,000 Japanese Yen ($ 541,000 U.S. Dollars based on the closing-date foreign exchange rate) of goodwill to the disposal group based on its relative fair value compared to the Company’s total fair value. Following the divestiture, the remaining goodwill associated with the continuing reporting unit was supported by a substantial excess of fair value of the reporting unit over its carrying value, and therefore no impairment charge was recognized.
20
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
NOTE 14: Subsequent Events
On May 6, 2026, the Board declared a cash dividend of $ 0.085 per share. The dividend is payable on June 4, 2026 to all shareholders of record as of the close of business on May 21, 2026.
Additionally, on April 29, 2026, the shareholders of the Company approved an amendment to the Cognex Corporation 2023 Stock Option and Incentive Plan (the “2023 Plan”) to increase the maximum amount of shares of common stock available to be issued under the plan by 4,600,000 shares.
21
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.